Skip to main content

Table 3 Blood and urine parameters according to mean arterial pressure regimen (n = 26)

From: High mean arterial pressure target to improve sepsis-associated acute kidney injury in patients with prior hypertension: a feasibility study

Variables

At inclusion

Low-MAP target period

High-MAP target period

Mean intra-individual difference (95% CI)a

P values for Group-MAP interaction

P values for effect of MAP

Primary endpoint

      

 Creatinine clearance (mL/mn)a

34 (24)

32 (31)

58 (41)

25 (11, 39)

0.1

0.002

Secondary endpoints

      

 Serum creatinine (µmol/L)

142 (80)

150 (85)

141 (80)

− 10 (− 17, − 3)

0.5

0.03

 Urine creatinine (mmol/L)

7.3 (4.6)

7.7 (6.1)

6.5 (4.1)

− 1.1 (− 2.2, 0.05)

0.2

0.06

 Urine output (mL/kg/h)

0.7 (0.5)

0.8 (0.6)

1 (0.7)

0.2 (0, 0.4)

0.3

0.04

 Urine sodium (mmol/L)

44 (30)

40 (26)

59 (26)

6 (0.2, 13)

0.8

0.04

 Serum osmolality (mOsm/kg)

308 (18)

307 (18)

306 (15)

− 0.1 (− 2.1, 1.9)

0.2

0.8

 Urine osmolality (mOsm/kg)

436 (141)

456 (179)

433 (126)

3 (− 18, 25)

0.1

0.9

 Proteinuria (g/L)

1.2 (0.8)

1.1 (0.6)

1.2 (0.7)

0.07 (− 0.1, 0.3)

0.9

0.4

 Urine–plasma creatinine ratio

75 (72)

78 (86)

70 (71)

− 7 (− 21, 7)

0.8

0.1

 Fractional excretion of sodium

0.9 (1.1)

1.1 (1.7)

1.2 (1.4)

0.02 (− 0.2, 0.3)

0.8

0.8

 Fractional excretion of urea

31 (17)

32 (13)

36 (17)

2.2 (− 1.7, 6.1)

0.2

0.3

  1. Data are expressed as the mean (SD) and mean individual difference (IC95%) from low- to high-MAP target period
  2. P values for the within-subject comparisons between the low and the high-MAP target period a multivariate repeated-measures analysis of variance (MANOVA) including the order of assignment of MAP regimes and the KDIGO stage at inclusion as factors
  3. aCalculated using the UV/P formula
  4. MAP: mean arterial pressure; KeGFR: kinetic estimated glomerular filtration rate